Title : Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.

Pub. Date : 2006 Jan 1

PMID : 16397231






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bortezomib triggered a dose-dependent inhibition of vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) secretion by the MMECs, and reverse transcriptase-PCR confirmed drug-related down-regulation of VEGF, IL-6, insulin-like growth factor-I, Angiopoietin 1 (Ang1), and Ang2 transcription. Bortezomib interleukin 6 Homo sapiens
2 Bortezomib triggered a dose-dependent inhibition of vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) secretion by the MMECs, and reverse transcriptase-PCR confirmed drug-related down-regulation of VEGF, IL-6, insulin-like growth factor-I, Angiopoietin 1 (Ang1), and Ang2 transcription. Bortezomib interleukin 6 Homo sapiens
3 Bortezomib triggered a dose-dependent inhibition of vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) secretion by the MMECs, and reverse transcriptase-PCR confirmed drug-related down-regulation of VEGF, IL-6, insulin-like growth factor-I, Angiopoietin 1 (Ang1), and Ang2 transcription. Bortezomib interleukin 6 Homo sapiens